New combo therapy shows promise for kids with advanced melanoma
NCT ID NCT00539591
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase II study tested a combination of two drugs—peginterferon alfa-2b and temozolomide—in 29 children with high-risk melanoma that had spread or come back. The main goal was to see how well the tumors shrank and to check for side effects. The study also looked at how long children stayed cancer-free after treatment with peginterferon alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Peginterferon alfa-2b and temozolomide
What this could lead to
If successful, this combination could offer a new treatment option for children with advanced melanoma that cannot be removed by surgery.
What could go wrong
This is a small, early-phase study (Phase II) with only 29 participants, so results may not apply to all children. The drugs can cause serious side effects like severe mood changes and organ toxicity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rady Children's Hospital
San Diego, California, 92123, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
The Children's Cancer Hospital at UT M.D. Anderson Cancer Center
Houston, Texas, 77030, United States